Skip to content

Comparison of the effect of cerebellum tDCS and prefrontal in patients with multiple sclerosis

Comparison of the effect of cerebellum tDCS and prefrontal on gait parameters, balance and fatigue in patients with multiple sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220111053689N1
Enrollment
51
Registered
2022-03-03
Start date
2022-02-09
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis or other white matter disorders

Interventions

Intervention 1: Intervention group 1: in this group, the anodal tDCS is placed to stimulate the left dorsolateral prefrontal cortex (left DLPFC) across the F3 region and the reference electrode across

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Diagnosis of MS by a neurologist Relapsing Remitting MS and secondary progressive MS The EDSS score should be between 3.5 to 5

Exclusion criteria

Exclusion criteria: Severe mental and cardiac patients Patients who experience severe cognitive impairment and depression Orthopedic disorders that can negatively affect balance

Design outcomes

Primary

MeasureTime frame
Balance. Timepoint: Before intervention-After intervention. Method of measurement: Force plate.;Gait parameters. Timepoint: Before intervention-After intervention. Method of measurement: Motion analyze.;Balance. Timepoint: Before intervention-After intervention. Method of measurement: berg balance scale.;Balance. Timepoint: Before intervention-After intervention. Method of measurement: Timed Up ? Go test.;Fatigue. Timepoint: Before intervention-After intervention. Method of measurement: Fatigue Severity Scale (FSS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Jahantigh Akbari

Shahid Beheshti University of Medical Sciences

n.jahantigh.akbari@gmail.com+98 21 7754 8496

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026